Jeffrey L. Cummings - Publications, H-index & Citations

Back

Jeffrey L. Cummings

nevada system of higher education (nshe)

176H-index

1.5KPaper Count

17.0WCitation Count

Published Papers 419

Publication Date

Alzheimer’s Disease blood biomarkers measured through remote capillary sampling correlate with cognition in older adults

Nature Communications

IF15.7

2026-05-06

OAAI

Anne Corbett; Millie Sander-Long; Nicholas J. Ashton; Hanna Huber; Jakub Vavra; Luisa Sophie Braun-Wohlfahrt; Henrik Zetterberg; Laia Montoliu-Gaya; Jeffrey Cummings; Freya Bateman; Christine Davis; Clive Ballard

Save

Alzheimer's disease drug development pipeline: 2026

alzheimer's & dementia: translational research & clinical interventions

IF0

2026-05-05

OAAI

Jeffrey L. Cummings; Yadi Zhou; Yuxin Yang; Kate Zhong; Jorge Fonseca; Amanda Leisgang Osse; Feixiong Cheng

Save

Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease

Nature Medicine

IF50

2026-04-01

PREAI

Cummings, Jeffrey L.; Agadjanyan, Michael G.; Barry, Maureen; Corey, Lawrence; Doody, Rachelle; Hendrix, Suzanne; Mattke, Soeren; Mattsson-Carlgren, Niklas; Mcdade, Eric; Menetski, Joseph P.; Mohs, Richard C.; Partrick, Katherine A.; Petrovsky, Nikolai; Selkoe, Dennis J.; Silva, Diego; Sperling, Reisa A.; Tiede, Benjamin; Vradenburg, George

Save

Efficacy of Brexpiprazole on Neuropsychiatric Symptoms and Impact on Caregivers: Pooled Neuropsychiatric Inventory (NPI) Analysis in Patients With Agitation Associated With Dementia due to Alzheimer’s Disease

Journal of Geriatric Psychiatry and Neurology

IF2.5

2025-12-24

OAAI

George T Grossberg; Marwan N Sabbagh; Sanjeda R Chumki; David Wang; Pedro Such; Zhen Zhang; Anton M Palma; Jeffrey L Cummings

Save

Repurposing glucagon-like peptide-1 receptor agonists for the treatment of neurodegenerative disorders

Nature Aging

IF19.4

2025-12-19

PREAI

Marwan N. Sabbagh; Jeffrey L. Cummings; Clive Ballard; Wiesje M. van der Flier; Michael T. Heneka; Jens Juul Holst; Lotte Bjerre Knudsen; Stephen Salloway; Malú Gámez Tansey; Daniel J. Drucker

Save

Characterizing Neurobehavioral Dysregulation Among Former American Football Players: Findings From the DIAGNOSE CTE Research Project

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

IF2.9

2025-12-01

PREAI

Pulukuri, Surya V.; Fagle, Tessa R.; Trujillo-Rodriguez, Diana; van Amerongen, Suzan; Bernick, Charles; Geda, Yonas E.; Wethe, Jennifer V.; Peskind, Elaine R.; Katz, Douglas I.; Alosco, Michael L.; Palmisano, Joseph N.; Tripodis, Yorghos; Adler, Charles H.; Balcer, Laura J.; Reiman, Eric M.; Shenton, Martha E.; Cummings, Jeffrey L.; Stern, Robert A.

Save

Globalization of Alzheimer's disease clinical trials: Current characteristics and future goals

INTERNATIONAL PSYCHOGERIATRICS

IF4.3

2025-12-01

OAAI

Cummings, Jeffrey L.; Lindle, Josie; Dalla, Ibrahim; Zhou, Yadi; Zhong, Kate; Cheng, Feixiong

Save

Clinical trials for neuropsychiatric syndromes in major and mild neurocognitive disorders: A CONSORT-based approach

INTERNATIONAL PSYCHOGERIATRICS

IF4.3

2025-12-01

OAAI

Cummings, Jeffrey L.; Zhong, Kate; Ballard, Clive; Sano, Mary; Mintzer, Jacobo

Save

Assessing safety and efficacy in subpopulations in Alzheimer's disease clinical trials: contextualizing representativeness

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS

IF6.8

2025-11-29

OAAI

Shan, Guogen; Cummings, Jeffrey

Save

Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders

INTERNATIONAL PSYCHOGERIATRICS

IF4.3

2025-09-01

OAAI

Sankhe, K.; Bawa, K. K.; Miller, D. S.; Bateman, D.; Cummings, J. L.; Ereshefsky, L.; Husain, M.; Ismail, Z.; Manera, V.; Mintzer, J.; Moebius, H. J.; Mortby, M.; Porsteinsson, A.; Robert, P.; Lanctot, K. L.

Save

Implementing early detection of cognitive impairment in primary care to improve care for older adults

Journal of Internal Medicine

IF9.2

2025-05-23

OAAI

Nicole R. Fowler; Katherine A. Partrick; James Taylor; Michael Hornbecker; Kevin Kelleher; Malaz Boustani; Jeffrey L. Cummings; Tim MacLeod

Save

Biomarker-guided decision making in clinical drug development for neurodegenerative disorders

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2025-04-04

PREAI

Cummings, Jeffrey L.; Teunissen, Charlotte E.; Fiske, Brian K.; Le Ber, Isabelle; Wildsmith, Kristin R.; Schoell, Michael; Dunn, Billy; Scheltens, Philip

Save

Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer's disease: Strategies and research directions

NEUROTHERAPEUTICS

IF6.9

2025-04-01

OAAI

Cummings, JL

Save

Human herpesvirus-associated transposable element activation in human aging brains with Alzheimer's disease

ALZHEIMERS & DEMENTIA

IF11.1

2025-02-22

OAAI

Feng, YY; Cao, SQ; Shi, Y; Sun, AN; Flanagan, ME; Leverenz, JB; Pieper, AA; Jung, JU; Cummings, J; Fang, EF; Zhang, PY; Cheng, FX

Save

Dispersion-based cognitive intra-individual variability in former American football players: Association with traumatic encephalopathy syndrome, repetitive head impacts, and biomarkers

CLINICAL NEUROPSYCHOLOGIST

IF2.7

2025-01-26

PREAI

Altaras, Caroline; Ly, Monica T.; Schultz, Olivia; Barr, William B.; Banks, Sarah J.; Wethe, Jennifer V.; Tripodis, Yorghos; Adler, Charles H.; Balcer, Laura J.; Bernick, Charles; Zetterberg, Henrik; Blennow, Kaj; Ashton, Nicholas; Peskind, Elaine; Cantu, Robert C.; Coleman, Michael J.; Lin, Alexander P.; Koerte, Inga K.; Bouix, Sylvain; Daneshvar, Daniel; Dodick, David W.; Geda, Yonas E.; Katz, Douglas L.; Weller, Jason L.; Mez, Jesse; Palmisano, Joseph N.; Martin, Brett; Cummings, Jeffrey L.; Reiman, Eric M.; Shenton, Martha E.; Stern, Robert A.; Alosco, Michael L.

Save

evoke and evoke plus : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2025-01-08

OAAI

Cummings, Jeffrey L.; Atri, Alireza; Feldman, Howard H.; Hansson, Oskar; Sano, Mary; Knop, Filip K.; Johannsen, Peter; Leon, Teresa; Scheltens, Philip

Save

Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway

ALZHEIMERS & DEMENTIA

IF11.1

2024-12-19

OAAI

Elhage, Aya; Cohen, Sharon; Cummings, Jeffrey; van der Flier, Wiesje M.; Aisen, Paul; Cho, Min; Bell, Joanne; Hampel, Harald

Save

Appropriate use of meaningful within-patient change (MWPC) thresholds in Alzheimer's disease

ALZHEIMERS & DEMENTIA

IF11.1

2024-12-18

OAAI

Lansdall, Claire J.; Cummings, Jeffrey L.; Andrews, Jeffrey Scott

Save

Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease

ALZHEIMERS & DEMENTIA

IF11.1

2024-12-06

PREAI

Xu, Jielin; Song, Wenqiang; Xu, Zhenxing; Danziger, Michael M.; Karavani, Ehud; Zang, Chengxi; Chen, Xin; Li, Yichen; Paz, Isabela M. Rivera; Gohel, Dhruv; Su, Chang; Zhou, Yadi; Hou, Yuan; Shimoni, Yishai; Pieper, Andrew A.; Hu, Jianying; Wang, Fei; Rosen-Zvi, Michal; Leverenz, James B.; Cummings, Jeffrey; Cheng, Feixiong

Save

Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players

ALZHEIMERS & DEMENTIA

IF11.1

2024-10-01

OAAI

Miner, Annalise E.; Groh, Jenna R.; Tripodis, Yorghos; Adler, Charles H.; Balcer, Laura J.; Bernick, Charles; Zetterberg, Henrik; Blennow, Kaj; Peskind, Elaine; Ashton, Nicholas J.; Gaudet, Charles E.; Martin, Brett; Palmisano, Joseph N.; Banks, Sarah J.; Barr, William B.; Wethe, Jennifer V.; Cantu, Robert C.; Dodick, David W.; Katz, Douglas I.; Mez, Jesse; van Amerongen, Suzan; Cummings, Jeffrey L.; Shenton, Martha E.; Reiman, Eric M.; Stern, Robert A.; Alosco, Michael L.

Save

Research Directions